- Home
- SYNX vs BRTX Comparison
SYNX vs BRTX Comparison
Compare SYNX & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYNX
- BRTX
- Stock Information
- Founded
- SYNX 2005
- BRTX 1997
- Country
- SYNX Israel
- BRTX United States
- Employees
- SYNX N/A
- BRTX N/A
- Industry
- SYNX
- BRTX Managed Health Care
- Sector
- SYNX
- BRTX Health Care
- Exchange
- SYNX Nasdaq
- BRTX Nasdaq
- Market Cap
- SYNX 11.4M
- BRTX 12.6M
- IPO Year
- SYNX 2024
- BRTX N/A
- Fundamental
- Price
- SYNX N/A
- BRTX $1.55
- Analyst Decision
- SYNX
- BRTX Strong Buy
- Analyst Count
- SYNX 0
- BRTX 1
- Target Price
- SYNX N/A
- BRTX $18.00
- AVG Volume (30 Days)
- SYNX 134.1K
- BRTX 261.0K
- Earning Date
- SYNX 05-14-2025
- BRTX 08-12-2025
- Dividend Yield
- SYNX N/A
- BRTX N/A
- EPS Growth
- SYNX N/A
- BRTX N/A
- EPS
- SYNX N/A
- BRTX N/A
- Revenue
- SYNX $9,094,000.00
- BRTX $391,000.00
- Revenue This Year
- SYNX $32.35
- BRTX $391.52
- Revenue Next Year
- SYNX N/A
- BRTX $3.50
- P/E Ratio
- SYNX N/A
- BRTX N/A
- Revenue Growth
- SYNX 19.14
- BRTX 161.54
- 52 Week Low
- SYNX $1.56
- BRTX $1.21
- 52 Week High
- SYNX $6.49
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- SYNX 46.39
- BRTX 40.71
- Support Level
- SYNX $1.56
- BRTX $1.57
- Resistance Level
- SYNX $1.91
- BRTX $1.72
- Average True Range (ATR)
- SYNX 0.18
- BRTX 0.10
- MACD
- SYNX -0.01
- BRTX -0.01
- Stochastic Oscillator
- SYNX 22.22
- BRTX 2.61
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.